دورية أكاديمية

(18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma.

التفاصيل البيبلوغرافية
العنوان: (18)F-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma.
المؤلفون: Regelink JC; Department of Haematology, VU University Medical Center, Amsterdam, The Netherlands. jc.regelink@meandermc.nl.; Department of Internal Medicine, Meander Medical Centre, Amersfoort, The Netherlands. jc.regelink@meandermc.nl., Raijmakers PG; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., Bravenboer N; Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands., Milek R; Janssen-Cilag B.V., Tilburg, The Netherlands., Hoetjes NJ; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., de Kreuk AM; Department of Internal Medicine, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands., van Duin M; Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Wondergem MJ; Department of Haematology, VU University Medical Center, Amsterdam, The Netherlands., Lips P; Endocrine Section, Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands., Sonneveld P; Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Zijlstra JM; Department of Haematology, VU University Medical Center, Amsterdam, The Netherlands., Zweegman S; Department of Haematology, VU University Medical Center, Amsterdam, The Netherlands.
المصدر: EJNMMI research [EJNMMI Res] 2016 Dec; Vol. 6 (1), pp. 46. Date of Electronic Publication: 2016 May 31.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Berlin Country of Publication: Germany NLM ID: 101560946 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2191-219X (Print) Linking ISSN: 2191219X NLM ISO Abbreviation: EJNMMI Res Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Heidelberg : Springer Berlin
مستخلص: Background: Bone disease in multiple myeloma is characterized by reduced bone formation. The gold standard of bone formation is the mineral apposition rate (MAR), an invasive technique reflecting bone formation at a single site. We compared (18)F-fluoride-PET with the MAR in myeloma patients.
Methods: Bone formation was measured before and after bortezomib treatment by determination of the MAR in iliac bone marrow biopsies and the measurement of (18)F-uptake.
Results: The inter- and intra-individual variations in (18)F-uptake (SUVA50%) were pronounced as 33.50 (range 4.42 to 37.92) and 27.18 (range 4.00 to 31.18), respectively. A significant correlation between the MAR and (18)F-uptake was found (r = 0.80, p = 0.017). There was a heterogeneous response after treatment varying from -2.20 to 4.53.
Conclusions: Iliac (18)F-uptake was associated with the local MAR in myeloma patients. Furthermore, (18)F-fluoride-PET demonstrated the heterogeneity of in vivo bone formation, enabling monitoring during treatment.
References: Eur J Haematol. 2011 Jan;86(1):83-6. (PMID: 20946110)
AJR Am J Roentgenol. 2014 Aug;203(2):263-71. (PMID: 25055258)
J Nucl Med. 2014 Jul;55(7):1122-7. (PMID: 24868107)
J Clin Endocrinol Metab. 1993 Oct;77(4):949-55. (PMID: 8408470)
J Nucl Med. 2001 Jul;42(7):1091-100. (PMID: 11438633)
J Nucl Med. 1992 May;33(5):633-42. (PMID: 1569473)
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1117-27. (PMID: 22526960)
Blood. 2007 Jul 1;110(1):334-8. (PMID: 17371942)
Osteoporos Int. 2013 Feb;24(2):633-9. (PMID: 22581294)
Br J Haematol. 2006 Dec;135(5):688-92. (PMID: 17107351)
Int J Cancer. 2012 Sep 15;131(6):1466-71. (PMID: 22052418)
Blood. 2006 Dec 15;108(13):3992-6. (PMID: 16917004)
Leukemia. 2007 Sep;21(9):2025-34. (PMID: 17581612)
تواريخ الأحداث: Date Created: 20160602 Date Completed: 20160601 Latest Revision: 20200929
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC4887457
DOI: 10.1186/s13550-016-0197-4
PMID: 27246327
قاعدة البيانات: MEDLINE
الوصف
تدمد:2191-219X
DOI:10.1186/s13550-016-0197-4